Dr Jayne Spink: key facts
- Kind of voice
- Sector leader
- Role
- Translational Research Director
- Organisation
- Prostate Cancer Research
- Organisation based in
- Holborn and St Pancras
- Quoted on
- Hospital discharge / bed-blocking, Cancer
- Tracked press citations
- 2
- Most recently quoted
- 27 Aug 2026
Who Dr Jayne Spink is
Dr Jayne Spink is Translational Research Director at Prostate Cancer Research (PCR), a UK charity that funds medical research projects at leading institutions across the prostate cancer field, from early-stage science to drug development. She holds a BSc in Genetics and a PhD from Cambridge University and spent her early career as a post-doctoral molecular and cellular research scientist. Before joining PCR she served as a principal scientist with the Department of Health focusing on genetics, genomics and gene therapy, and as Associate Director of the Centre for Clinical Practice at NICE. She was previously Director of Policy and Research at the MS Society, the first ever CEO of the Tuberous Sclerosis Association (for five years), and subsequently CEO of Genetic Alliance UK, the national charity working to improve the lives of patients and families affected by genetic conditions. At PCR she is known for championing early-stage prostate cancer diagnosis, supporting commercial translational research, and co-leading the charity's prostate cancer data registry work.
“Many men don't come forward because prostate cancer often has no symptoms in the early stages, and some don't realise they are at higher risk. This means that we are diagnosing far too many men when their cancer is already advanced and becomes incurable”
References for this biography
- 1.Newcastle firm lands £1.85m cancer nanorobot funding – Prolific North — Confirms role title 'Translational Research Director at Prostate Cancer Research' and her public advocacy on early prostate cancer diagnosis
- 2.Prostate Cancer Registry – Update – Prostate Cancer Research — Confirms role title and her involvement in PCR's prostate cancer data registry and 'Unlocking the Potential of Prostate Cancer Data' report
- 3.Dr Jayne Spink – ProvenConnect.com — Confirms PhD from Cambridge University, post-doctoral background, Department of Health and NICE roles, and third-sector leadership experience
- 4.Our Press and PR team – Prostate Cancer Research — Confirms BSc in Genetics and PhD from Cambridge University, post-doctoral background, DHSC and NICE Associate Director roles, and PCR affiliation
- 5.Jayne Spink, CEO, leaves to take the lead at Genetic Alliance UK – Tuberous Sclerosis Association — Confirms she was the first ever CEO of the Tuberous Sclerosis Association and left to become CEO of Genetic Alliance UK
- 6.Rare disease Minister announces National Genomics Healthcare Strategy – Genetic Alliance UK — Confirms her role as Chief Executive of Genetic Alliance UK and her public advocacy on genomics healthcare strategy
- 7.Jayne Spink – Evidence EU speaker profile — Confirms her previous roles: Director of Policy & Research at the MS Society, Associate Director of the Centre for Clinical Practice at NICE, and Head of Genetic Science Safety and Regulation at the Department of Health
- 8.PROSTATE CANCER RESEARCH – Charity Commission — Confirms Prostate Cancer Research head-office address (Suite 2, 23-24 Great James Street, London WC1N 3ES) and general contact details
Notable achievements
- Led Q&A on PCR's 'Unlocking the Potential of Prostate Cancer Data' report as Translational Research Director at a December 2022 webinar on the PCR prostate cancer registry Source ↗
- As CEO of Genetic Alliance UK, publicly called on government to commit to a National Genomics Healthcare Strategy at the charity's Rare Disease Day reception in Westminster Source ↗
- Served as the first ever CEO of the Tuberous Sclerosis Association for five years, before leaving to become CEO of Genetic Alliance UK Source ↗
- Quoted in press coverage of the £1.85m nanorobot cancer diagnostics funding (Nanovery/PCR partnership), advocating the importance of early-stage prostate cancer diagnosis Source ↗
What Dr Jayne Spink has said
“If prostate, breast or ovarian cancer runs in your family, particularly at younger ages, it's important to speak to your GP about your own risk.”
translational research director at Prostate Cancer Research · Cancer · 27 Aug 2026 · What is prostate cancer and should I be worried if I wee a lot at night? ↗
Where Dr Jayne Spink has been quoted
- Mixed messages on prostate cancer testing proved deadly for my husband | Lettertheguardian.com · 27 Aug 2026
- What is prostate cancer and should I be worried if I wee a lot at night?theguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Contact & links
- Staff pagehttps://www.prostate-cancer-research.org.uk/about-us/pcrc-staff/
- Websitehttps://www.provenconnect.com/our-people/dr-jayne-spink/
- Press office emailinfo@pcr.org.ukpublished here ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.